Aerpio Pharmaceuticals, Inc. (ARPO): Price and Financial Metrics
ARPO Price/Volume Stats
Current price | $33.00 | 52-week high | $34.50 |
Prev. close | $2.22 | 52-week low | $0.95 |
Day low | $32.40 | Volume | 55,066 |
Day high | $34.50 | Avg. volume | 5,147,753 |
50-day MA | $2.04 | Dividend yield | N/A |
200-day MA | $1.64 | Market Cap | 1.57B |
ARPO Stock Price Chart Interactive Chart >
Aerpio Pharmaceuticals, Inc. (ARPO) Company Bio
Aerpio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for ocular diseases. The company's lead product candidate is AKB-9778, a small molecule activator of the Tie2 pathway, which completed the Phase 2a clinical trial for the treatment of diabetic retinopathy. It also develops ARP-1536, a humanized monoclonal antibody that is in preclinical development stage for the treatment of diabetic vascular complications; and AKB-4924, a selective stabilizer of hypoxia-inducible factor-1 alpha, which has completed a single ascending dose clinical trial for the treatment of inflammatory bowel disease. The company is based in Cincinnati, Ohio
ARPO Price Returns
1-mo | N/A |
3-mo | N/A |
6-mo | N/A |
1-year | N/A |
3-year | N/A |
5-year | 312.84% |
YTD | N/A |
2023 | N/A |
2022 | N/A |
2021 | 0.00% |
2020 | 57.18% |
2019 | -63.32% |
Continue Researching ARPO
Here are a few links from around the web to help you further your research on Aerpio Pharmaceuticals Inc's stock as an investment opportunity:Aerpio Pharmaceuticals Inc (ARPO) Stock Price | Nasdaq
Aerpio Pharmaceuticals Inc (ARPO) Stock Quote, History and News - Yahoo Finance
Aerpio Pharmaceuticals Inc (ARPO) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...